SGXP (SGX Pharmaceutica)
All Pro Portfolios with SGXP
All Do-It-Yourself Portfolios with SGXP
- Total Do-It-Yourself Portfolios with SGXP:
- 2006 IPO Losers
- Nazdaqcom Portfolio 1
- SUPRATRADE-1009071206
- show more
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
By:barrons2 |
Date:07 19 08 |
BVF intends to explore, with SGX and others, alternatives to SGX's proposed acquisition by Eli Lilly (LLY). BVF said that the alternatives may include the continued independence of SGX, possibly financed through a non-dilutive rights offering with existing shareholders. BVF also may explore strategic collaborations with third parties or a sale of SGX, in whole or in part, under terms other than those that Lilly has proposed. Eli Lilly has agreed to buy the San Diego biotech outfit for $3 a share, or $64 million, subject to the approval of SGX shareholders. BVF owns 5,905,274 shares (28.6%). |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Upgraded by JMP Securities from Mkt Underperform to Mkt Outperform |
|
Not yet rated
Rate now:
|
|
By:JERZEEJIM |
Date:01 20 07 |
CRAWLING UP FROM 52 WEEK LOW- HAS PROPRIETARY PLATFORM- F A S T |
|
Not yet rated
Rate now:
|
|
By:Guest |
Date:11 30 -1 |
IPO date: 2-1-2006 |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
| Comments not available |
